Up a level |
Vartak, V Supriya and Lyer, Divyaanka and Santhoshkumar, T R and Sharma, Sheetal and Mishra, Archita and Goldsmith, Gunaseelan and Srivastava, Amrinal and Srivastava, Shikha and Karki, S Subhas and Surolia, Avadhesha and Choudhary, Bibha and Raghavan, S Sathees (2017) Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction. In: BIOCHEMICAL PHARMACOLOGY, 131 . pp. 16-28.
Vartak, Supriya V and Hegde, Mahesh and Iyer, Divyaanka and Gaikwad, Snehal and Gopalakrishnan, Vidya and Srivastava, Mrinal and Karki, Subhas S and Choudhary, Bibha and Ray, Pritha and Santhoshkumar, T R and Raghavan, Sathees C (2016) A novel inhibitor of BCL2, Disarib abrogates tumor growth while sparing platelets, by activating intrinsic pathway of apoptosis. In: BIOCHEMICAL PHARMACOLOGY, 122 . pp. 10-22.